Salesforce Announces AI Cloud – Bringing Trusted Generative AI to the Enterprise
AI Cloud is built for CRM – supercharging customer experiences and company productivity by bringing…
News
TriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual Meeting
New data from PERIO-01 clinical trial indicates PEDD™ method resulted in modulation of the tumor…
WisdomTree Critically Needs the Appropriate Board to Oversee Strategy and Continue Its Growth Trajectory
Our Board is Refreshed, Diverse and Well-Qualified – We Cannot Afford to Lose the Vital…
DUCKble The Joy, DUCKble The Fun! Campaign Launches!
HONG KONG, Jun 12, 2023 – (ACN Newswire) – DOTTED, the mobile-first Web3 platform founded…
Satellite Operators Maintain a Positive Outlook on The Future of The Industry and Talk Up Integration, Adaptation and Cooperation
SINGAPORE, Jun 12, 2023 – (ACN Newswire) – On June 6, the Asia Video Industry…
Insight Survey Finds Pace of Innovation Accelerating; Falling Behind in Digital Transformation More Impactful Than a Recession
Despite increased scrutiny of technology investments, new era of innovation calls for a digital-first mindset…
Digital Therapeutics Alliance and Healthware Group Launched First DTx Policy Report and Website Dedicated to Helping Advance Equitable Access and Adoption of Safe and Effective DTx and Digital Medical Devices
MILAN & WASHINGTON–(BUSINESS WIRE)–Following the formation of the European DTx Policy Coalition by Healthware Group…
Appen Appoints Fab Dolan as Chief Marketing Officer
KIRKLAND, Wash.–(BUSINESS WIRE)–Appen Limited (ASX:APX), a global leader in providing data services for deep learning…
BC Platforms Expands Data Partner Network with Major Brazilian Cardiovascular Health Institution
Enables access to additional Latin America data to support equitable healthcare in cardiovascular R&D ZURICH,…
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to…
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to…
Novo Nordisk invests DKK 15.9 bn in expansion of manufacturing facilities in Hillerød, Denmark
Bagsværd, Denmark, 12 June 2023 – Novo Nordisk today announced plans to invest 15.9 billion…
Mendus presents comprehensive ADVANCE II immunomonitoring data at the EHA Annual Meeting 2023
VIDIDENCEL ADMINISTRATION LED TO BROAD IMMUNE ACTIVATION WITH INNATE AND ADAPTIVE IMMUNE RESPONSES OBSERVED Mendus…
Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness
PRESS RELEASE Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation…
Oxurion Finalizes Enrollment in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema
Top-line Data Expected in Q4 2023 Leuven, BELGIUM, Boston, MA, US – June 12, 2023…
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Poland
LISBON, Portugal, June 12, 2023 (GLOBE NEWSWIRE) — SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”) has entered…
Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG
Novartis to acquire Chinook for $40 per share in cash, with potential to receive up…
Novartis bolsters innovative medicines strategy and renal pipeline with agreement to acquire Chinook Therapeutics for USD 3.2bn upfront (USD 40 / share)
Ad hoc announcement pursuant to Art. 53 LR Chinook Therapeutics is a clinical-stage biopharmaceutical company…
Ipsen to present new data on clinical outcomes and patient validation tools from growing rare liver disease portfolio at EASL 2023
Seven abstracts to be presented demonstrating treatment effects of Bylvay® in two cholestatic liver diseases,…
Idorsia launches QUVIVIQ (daridorexant) in Switzerland – a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning
QUVIVIQ™ is indicated for the treatment of adult patients with insomnia, characterized by symptoms present…